Kohei shitara (@KoheiShitara) / X
Por um escritor misterioso
Descrição
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
Jeroen Dekervel (@JDekervel) / X
Kohei Shitara, MD @KoheiShitara @theNCI @NCIResearchCtr #ASCOGI21 #GastrointestalCancer #GICancer #Cancer #Research P
Susumu Kobayashi (@SusumuKobayas10) / X
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Joseph J Zhao (@josephjzhao) / X
Raghav Sundar (@sundar__raghav) / X
Angelica Petrillo (@AngelicaSSophie) / X
Oncology Data Advisor - Zolbetuximab: Gastric/Gastroesophageal Junction Adenocarcinoma
Kohei shitara (@KoheiShitara) / X